Why Dapagliflozin Spans Diabetes, Heart Failure, and Kidney Disease
Dapagliflozin, sold as Forxiga in some markets, has moved beyond its early role as a diabetes drug. It is now part of care pathways for type 2 diabetes, chronic kidney disease, and heart failure. That shift reflects a broader change in medicine: doctors are trying to protect organs earlier, not only lower blood sugar or […]
Why Dapagliflozin Spans Diabetes, Heart Failure, and Kidney Disease Read More »









